Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Esophageal Squamous Cell Carcinoma × Magnetic Resonance Imaging × 1 year × Clear all

Sponsor

Conditions

Prostatic Neoplasms 6 Neoplasms 6 Breast Neoplasms 6 Pancreatic Neoplasms 5 Brain Neoplasms 5 Lymphoma, Non-Hodgkin 4 Lymphoma 4 Uterine Cervical Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Lung Neoplasms 3 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Liver Neoplasms 2 Leukemia 2 Hodgkin Disease 2 Glioma 2 Esophageal Neoplasms 2 Central Nervous System Neoplasms 2 Carcinoma, Neuroendocrine 2 Carcinoma in Situ 2 Burkitt Lymphoma 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Uterine Cervical Dysplasia 1 Thoracic Neoplasms 1 Thoracic Diseases 1 Squamous Cell Carcinoma of Head and Neck 1 Spinal Diseases 1 Spinal Cord Neoplasms 1 Rectal Neoplasms 1

Interventions

Cisplatin 22 Paclitaxel 17 pembrolizumab 14 Carboplatin 12 Radiotherapy 11 tislelizumab 9 Drug Therapy 9 Fluorouracil 8 toripalimab 7 Nivolumab 7 Irinotecan 7 Esophagectomy 6 Neoadjuvant Therapy 5 Docetaxel 5 Radiation 4 Oxaliplatin 4 Capecitabine 4 Albumin-Bound Paclitaxel 4 130-nm albumin-bound paclitaxel 4 nimotuzumab 3 lenvatinib 3 Taxes 3 Levoleucovorin 3 Leucovorin 3 spartalizumab 2 sintilimab 2 regorafenib 2 nedaplatin 2 durvalumab 2 apatinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡